What is CAR-T?
Learn more about the CAR-T Therapy
and CAR-T Technology
What is CAR-T?
Learn more about the CAR-T Therapy
and CAR-T Technology
What is CAR-T?
Learn more about the CAR-T Therapy
and CAR-T Technology
This webcast is for you who come in contact with patients with Hematological Malignancies. The webcast will cover The History of CAR-T and Key Milestones, Overview of CAR-T Therapy and the Overview of Patient Experience, Basic CAR Engineering Principles and The Evolution of CAR Design. Bring your lunch with you and participate in the meeting. At the end you will have the opportunity to ask questions to the Faculty.
- CAR-T construct design which is an evolving process, and differences in
construct design may affect efficacy and safety of the product - The Overview of CAR-T Therapy
- The Overview of Patient Experience
- Basic CAR Engineering Principles
- The Evolution of CAR Design
Nordic Medical Advisor
Janssen Cell Therapy Department
Nordic Business Unit Lead Cell Therapy
Janssen Cell Therapy Department

Åse Rosenqvist
Lead Cell Therapy
Janssen-Cilag AB
Mobile: +46 738 03 92 54
arosenq1@its.jnj.com

Fredrik Jerhammar
Nordic Medical Advisor
Cell Therapy
Janssen-Cilag AB
Mobile: +46 738 24 34 61
fjerhamm@its.jnj.com
Upcoming Webinars
Bo. Nam am eicte pro quunt omnime diosaer eptam, sus. Ibus, nonectae nos autatem int ressequi offic totat vel inulparum que nus. Niscianimo bla il ea quo corum fugiant et et quatiundae eritatius vellum a cus aut labo. Nemporeicae quame mod magnati aspedi temporecto cus, ut est quis ium dolorpo ssequiatur mincilia eos
Recorded Webinars
Bo. Nam am eicte pro quunt omnime diosaer eptam, sus. Ibus, nonectae nos autatem int ressequi offic totat vel inulparum que nus. Niscianimo bla il ea quo corum fugiant et et quatiundae eritatius vellum a cus aut labo. Nemporeicae quame mod magnati aspedi temporecto cus, ut est quis ium dolorpo ssequiatur mincilia eos
Janssen Cell Therapy Team
Bo. Nam am eicte pro quunt omnime diosaer eptam, sus. Ibus, nonectae nos autatem int ressequi offic totat vel inulparum que nus. Niscianimo bla il ea quo corum fugiant et et quatiundae eritatius vellum a cus aut labo. Nemporeicae quame mod magnati aspedi temporecto cus, ut est quis ium dolorpo ssequiatur mincilia eos
Webinar #2:
CAR-T Certification
Date: Tuesday,
November 21, 2023
Time: 15.00–16.00
Thursday, November 16, 2023
15:00–16:00 CET
What is
CAR-T?
Learn more about the CAR-T Therapy
and CAR-T Technology
Agenda
| 15:00 | Welcome & Introduction Åse Rosenqvist |
| 15:05 | What is CAR-T? Fredrik Jerhammar |
| 15:40 | Q&A |
| 15:55 | Summary Åse Rosenqvist |
| 16:00 | Closing |